Verve Therapeutics Stock (NASDAQ: VERV) stock price, news, charts, stock research, profile.
Open | $6.900 |
Close | $6.880 |
Volume / Avg. | 965.009K / 1.282M |
Day Range | 6.810 - 7.410 |
52 Wk Range | 6.420 - 21.420 |
Market Cap | $600.386M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 23.71% |
Days to Cover | 21.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.
Other companies in Verve Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO) and Pharming (NASDAQ:PHAR).
The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by Stifel on Wednesday, April 3, 2024. The analyst firm set a price target for 40.00 expecting VERV to rise to within 12 months (a possible 457.10% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Verve Therapeutics (NASDAQ: VERV) is $7.18 last updated April 23, 2024 at 6:25 PM EDT.
There are no upcoming dividends for Verve Therapeutics.
Verve Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Verve Therapeutics.
Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.